Kazuya Shimoda

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Tyrosine Kinase

Pulmonary Hypertension

Acute Lymphoblastic Leukemia

Top Venues

International journal of hematology

Diabetes therapy : research, treatment and education of diabetes and related disorders

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuya Shimoda, Albert Qin, Norio Komatsu, Keita Kirito
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b. International journal of hematology 120 (2) (2024)
Kazuya Shimoda, Norio Komatsu, Itaru Matsumura, Kazuhiko Ikeda, Masayuki Hino, Michihiro Hidaka, Yoshinobu Maeda, Takeshi Kondo, Tomoaki Fujisaki, Keita Shoshi, Kyoichi Azuma, Ryuichi Fukushima, Jun Kawashima, Hiroshi Kosugi
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial. International journal of hematology 120 (3) (2024)
Kazuya Shimoda, Albert Qin, Norio Komatsu, Keita Kirito
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b. International journal of hematology (2024)
Kensuke Usuki, Takuro Kameda, Noriaki Kawano, Tomoki Ito, Yoshinori Hashimoto, Kotaro Shide, Hiroshi Kawano, Masaaki Sekine, Takanori Toyama, Hiromitsu Iizuka, Seiichi Sato, Masanori Takeuchi, Junzo Ishizaki, Kouichi Maeda, Michikazu Nakai, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan. International journal of hematology 119 (6) (2024)
Kazuya Shimoda, Norio Komatsu, Itaru Matsumura, Kazuhiko Ikeda, Masayuki Hino, Michihiro Hidaka, Yoshinobu Maeda, Takeshi Kondo, Tomoaki Fujisaki, Keita Shoshi, Kyoichi Azuma, Ryuichi Fukushima, Jun Kawashima, Hiroshi Kosugi
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial. International journal of hematology 120 (3) (2024)
Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, Norio Abiru, Hitoe Mori, Hironori Kurisaki, Kazuya Shimoda, Yasunobu Yoshikai, Hirokazu Takahashi, Keizo Anzai
TYK2 signaling promotes the development of autoreactive CD8 + cytotoxic T lymphocytes and type 1 diabetes. Nature communications 15 (1) (2024)
Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, Norio Abiru, Hitoe Mori, Hironori Kurisaki, Kazuya Shimoda, Yasunobu Yoshikai, Hirokazu Takahashi, Keizo Anzai
TYK2 signaling promotes the development of autoreactive CD8 + cytotoxic T lymphocytes and type 1 diabetes. Nature communications 15 (1) (2024)
Kazuya Shimoda, Albert Qin, Norio Komatsu, Keita Kirito
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b. International journal of hematology 120 (2) (2024)
Kazuya Shimoda, Norio Komatsu, Itaru Matsumura, Kazuhiko Ikeda, Masayuki Hino, Michihiro Hidaka, Yoshinobu Maeda, Takeshi Kondo, Tomoaki Fujisaki, Keita Shoshi, Kyoichi Azuma, Ryuichi Fukushima, Jun Kawashima, Hiroshi Kosugi
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial. International journal of hematology 120 (3) (2024)
Kazuya Shimoda, Norio Komatsu, Itaru Matsumura, Kazuhiko Ikeda, Masayuki Hino, Michihiro Hidaka, Yoshinobu Maeda, Takeshi Kondo, Tomoaki Fujisaki, Keita Shoshi, Kyoichi Azuma, Ryuichi Fukushima, Jun Kawashima, Hiroshi Kosugi
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis: an efficacy/safety analysis in the Japanese subgroup of the phase 3 randomized SIMPLIFY-1 trial. International journal of hematology (2024)
Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, Norio Abiru, Hitoe Mori, Hironori Kurisaki, Kazuya Shimoda, Yasunobu Yoshikai, Hirokazu Takahashi, Keizo Anzai
TYK2 signaling promotes the development of autoreactive CD8 + cytotoxic T lymphocytes and type 1 diabetes. Nature communications 15 (1) (2024)
Kensuke Usuki, Takuro Kameda, Noriaki Kawano, Tomoki Ito, Yoshinori Hashimoto, Kotaro Shide, Hiroshi Kawano, Masaaki Sekine, Takanori Toyama, Hiromitsu Iizuka, Seiichi Sato, Masanori Takeuchi, Junzo Ishizaki, Kouichi Maeda, Michikazu Nakai, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan. International journal of hematology 119 (6) (2024)
Kensuke Usuki, Takuro Kameda, Noriaki Kawano, Tomoki Ito, Yoshinori Hashimoto, Kotaro Shide, Hiroshi Kawano, Masaaki Sekine, Takanori Toyama, Hiromitsu Iizuka, Seiichi Sato, Masanori Takeuchi, Junzo Ishizaki, Kouichi Maeda, Michikazu Nakai, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan. International journal of hematology (2024)
Kensuke Usuki, Takuro Kameda, Noriaki Kawano, Tomoki Ito, Yoshinori Hashimoto, Kotaro Shide, Hiroshi Kawano, Masaaki Sekine, Takanori Toyama, Hiromitsu Iizuka, Seiichi Sato, Masanori Takeuchi, Junzo Ishizaki, Kouichi Maeda, Michikazu Nakai, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan. International journal of hematology 119 (6) (2024)
Kazuya Shimoda, Albert Qin, Norio Komatsu, Keita Kirito
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b. International journal of hematology 120 (2) (2024)
Kensuke Usuki, Takuro Kameda, Noriaki Kawano, Tomoki Ito, Yoshinori Hashimoto, Kotaro Shide, Hiroshi Kawano, Masaaki Sekine, Takanori Toyama, Hiromitsu Iizuka, Seiichi Sato, Masanori Takeuchi, Junzo Ishizaki, Kouichi Maeda, Michikazu Nakai, Kiyoshi Yamashita, Yoko Kubuki, Kazuya Shimoda
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan. International journal of hematology 119 (6) (2024)
Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, Norio Abiru, Hitoe Mori, Hironori Kurisaki, Kazuya Shimoda, Yasunobu Yoshikai, Hirokazu Takahashi, Keizo Anzai
TYK2 signaling promotes the development of autoreactive CD8 + cytotoxic T lymphocytes and type 1 diabetes. Nature communications 15 (1) (2024)
Kazuya Shimoda, Albert Qin, Norio Komatsu, Keita Kirito
Efficacy and safety outcomes in Japanese patients with low-risk polycythemia vera treated with ropeginterferon alfa-2b. International journal of hematology 120 (2) (2024)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (3) (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (3) (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (3) (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
Improving the Effects of Imeglimin on Endothelial Function: A Prospective, Single-Center, Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, Kazuya Shimoda
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model. Blood cancer journal 13 (1) (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
A Response to Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus? Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
A Response to Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus? Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (6) (2023)
Taisuke Uchida, Hiroaki Ueno, Ayaka Konagata, Norifumi Taniguchi, Fumiko Kogo, Yuma Nagatomo, Koichiro Shimizu, Hideki Yamaguchi, Kazuya Shimoda
A Response to Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus? Diabetes therapy : research, treatment and education of diabetes and related disorders 14 (6) (2023)
Takuro Kameda, Kotaro Shide, Ayako Kamiunten, Yasunori Kogure, Daisuke Morishita, Junji Koya, Yuki Tahira, Keiichi Akizuki, Takako Yokomizo-Nakano, Sho Kubota, Kosuke Marutsuka, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Yuichi Kitai, Tadashi Matsuda, Akinori Yoda, Takayuki Ohshima, Midori Sugiyama, Goro Sashida, Keisuke Kataoka, Seishi Ogawa, Kazuya Shimoda
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma. Communications biology 5 (1) (2022)
Daisuke Shinoda, Yaeko Nakajima-Takagi, Motohiko Oshima, Shuhei Koide, Kazumasa Aoyama, Atsunori Saraya, Hironori Harada, Bahityar Rahmutulla, Atsushi Kaneda, Kiyoshi Yamaguchi, Yoichi Furukawa, Haruhiko Koseki, Kazuya Shimoda, Tomoaki Tanaka, Goro Sashida, Atsushi Iwama
Insufficiency of non-canonical PRC1 synergizes with JAK2V617F in the development of myelofibrosis. Leukemia (2021)
Yusuke Kimishima, Tomofumi Misaka, Tetsuro Yokokawa, Kento Wada, Koki Ueda, Koichi Sugimoto, Keiji Minakawa, Kazuhiko Nakazato, Takafumi Ishida, Motohiko Oshima, Shuhei Koide, Kotaro Shide, Kazuya Shimoda, Atsushi Iwama, Kazuhiko Ikeda, Yasuchika Takeishi
Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils. Nature communications 12 (1) (2021)
Ayako Kamiunten, Kotaro Shide, Takuro Kameda, Masafumi Ito, Masaaki Sekine, Yoko Kubuki, Tomonori Hidaka, Keiichi Akizuki, Yuki Tahira, Takanori Toyama, Noriaki Kawano, Kousuke Marutsuka, Kouichi Maeda, Masanori Takeuchi, Hiroshi Kawano, Seiichi Sato, Junzo Ishizaki, Haruko Shimoda, Kiyoshi Yamashita, Hitoshi Matsuoka, Kazuya Shimoda
Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia. International journal of hematology 108 (4) (2018)